Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09) Among 222 patients randomly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results